<DOC>
	<DOCNO>NCT01198925</DOCNO>
	<brief_summary>Piperacillin-tazobactam acylureido-penicillin-beta-lactamase inhibitor combination frequently use empirical treatment hospital-acquired infection antipseudomonal activity . Similar beta-lactam antibiotic , piperacillin-tazobactam exhibit time-dependent kill T &gt; MIC appear best outcome predictor . Because majority infection treat empirically , necessary achieve T &gt; MIC equal 50 % dose interval ( 50 % T &gt; MIC ) likely pathogen , include moderate susceptibility The aim study compare dose piperacillin/tazobactam administer extended infusion versus continuous infusion . A pharmacokinetic study perform patient treat extended ( load dose 4 G/30 min follow 4 X 4 G /3h ) continuous infusion ( load dose 4 G/30 min follow 16G /24h ) . A population pharmacokinetic analysis Monte Carlo simulation use determine 95 % probability target attainment ( PTA95 ) versus MIC</brief_summary>
	<brief_title>Assessment Optimal Dosing Piperacillin-tazobactam Intensive Care Unit Patients : Extended Versus Continuous Infusion</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<criteria>Adult patient ( &gt; 18 year ) admit intensive care unit ( surgical medical surgery ) . Starting treatment piperacillin/tazobactam Signed informed consent Hematocrit &gt; = 21 % Available arterial line age &lt; 18 &gt; 75 year patient 's weight &lt; 50 &gt; 100 kg renal insufficiency ( estimate clearance &lt; 50 ML /MIN ) haemodialysis WBC &lt; 1000 103 Âµl estimate survival &lt; 5 day meningitis proven infection CNS IgEmediated allergy penicillin pregnancy patient participate another study &lt; 30 day inclusion present study retrospectively , mark deterioration renal function study period retrospectively , treatment &lt; 96 h</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Infectious disease</keyword>
	<keyword>piperacillin</keyword>
	<keyword>continuous infusion</keyword>
	<keyword>extend infusion</keyword>
</DOC>